A Patient-Centric Hemostatic Strategy
When planning surgery, patient factors including coagulation status and bleeding severity should be at the core of your hemostatic strategy.
Patient profiles are changing; increasing the risk of bleeding complications.1
15%
of US adults have chronic kidney disease.2
30%
of the US population use low-dose aspirin for cardiovascular disease prevention.3
~2/3
of surgical patients are treated with anticoagulants and/or antiplatelets.*4
*Based on Premier Database data
~1 in 50
adults have liver disease.5
~2 in 5
adults will be diagnosed with cancer in their lifetime.6
Patients at the core.
Each patient is unique, with their own set of factors that impact their risk of bleeding related complications.
Some patients have an intact coagulation and relatively good health while others have compromised coagulation and existing comorbidities.
These factors can all influence the risk of bleeding7 and the performance of adjunctive hemostats agents and sealants.1